Le Lézard
Classified in: Health
Subjects: SVY, ESG

Danaher Releases 2024 Sustainability Report


WASHINGTON, July 16, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Report which conveys the depth and scope of Danaher's sustainability program and highlights important milestones the Company achieved during the past year.

"At the heart of everything we do at Danaher is our commitment to continuous improvement, and our sustainability program exemplifies this commitment," said Rainer Blair, President and Chief Executive Officer. "We remain focused on making meaningful progress every day and are proud of what we achieved this year across our sustainability initiatives."

This year's report details several key accomplishments across Danaher's sustainability strategic pillars:

Innovating Products That Improve Lives and Our Planet

Building the Best Team

Protecting Our Environment

Foundational Elements: Supply Chain Sustainability

Mr. Blair concluded, "Every day across Danaher, we work to positively impact the world around us in meaningful ways. We know that when we bring together the passion and dedication of our teams, the scope and scale of our innovations, and our deeply ingrained commitment to continuous improvement, Danaher's potential for long-term positive impact is limitless."

SUSTAINABILITY AT DANAHER
Danaher is committed to helping generations of our stakeholders by innovating products that improve lives and our planet, building the best team, and protecting our environment. Our dedication to continuous improvement drives us to positively impact the world around us every day and the Danaher Business System is a uniquely powerful system for supporting these ambitions. To learn more about Danaher's sustainability initiatives and to read or download the 2024 sustainability report, please visit www.danaher.com/sustainability

ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.

FORWARD-LOOKING STATEMENTS
Statements in this release that are not strictly historical, including any statements regarding events or developments that we anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, those set forth in our SEC filings, including our 2023 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the first quarter of 2024. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise. 

SOURCE Danaher Corporation


These press releases may also interest you

at 08:17
Today Mediplanet launches their Women in Research campaign, aimed at addressing gender disparities in the U.S. research workforce. Making up 30% of the research workforce, women continue to face systemic challenges, including gender bias, lack of...

22 mar 2025
Product: Dips Issue: Food - Allergen ? Peanut Distribution:     AlbertaBritish ColumbiaPossibly other provinces and territories See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

22 mar 2025
-The first Korean company granted Breakthrough Therapy Designation (BTD) from the U.S. FDA-Clinical trials and results from a three-year follow-up show significant improvements compared to existing treatments-The BTD designation, achieved following...

22 mar 2025
Investing in Canadians' health is key to building a stronger Canada. In its first year, the Canadian Dental Care Plan (CDCP) has significantly improved access to affordable dental care. More than 3.4 million Canadians were approved to be part of the...

22 mar 2025
Product: Organic Almond Butter Cup Issue: Food - Allergen ? Peanut Distribution:  National                      Online See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

22 mar 2025
The official brand behind Prime Biome has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports of unverified vendors listing non-official versions of Prime Biome across various platforms...



News published on and distributed by: